Comprehensive Study Guide on Hematopoietic System Alterations

Composition and Proportions of Living Blood Tissue

Blood is not merely a simple liquid but is accurately defined as a specialized connective tissue engineered for metabolic transport and systemic defense. Its total volume is divided into two primary compartments: Plasma and Formed Elements. Plasma constitutes $55\%$ of the blood volume and serves as the extracellular liquid component. It is composed of approximately $90\%$ water, functioning fundamentally as the primary transport vehicle for nutrients, hormones, and waste. The Formed Elements make up the remaining $45\%$ of the blood volume and consist of cells and cell fragments held in suspension. These include Erythrocytes, which are responsible for gas transport; Leukocytes, which manage immune defense; and Platelets (trombocitos), which are critical for hemostasis.

Plasma Proteins: The Osmotic and Transport Machinery

Plasma proteins constitute between $7\%\text{ to }8\%$ of the plasma volume and are almost entirely synthesized within the liver. They are categorized based on their functional roles and concentrations. Albumin is the most abundant protein ($54\%$), and its primary physiological role is maintaining colloidal osmotic (oncotic) pressure to prevent the formation of edema. Additionally, it serves as the main endogenous vehicle for transporting bilirubin and free fatty acids, as well as exogenous substances including penicillin and salicylates.

Globulins account for $38\%$ of plasma proteins and are subdivided into three types. Alpha-globulins transport bilirubin and steroids. Beta-globulins are responsible for transporting metals, specifically iron (via transferrin) and copper (via ceruloplasmin). Gamma-globulins, which constitute the antibodies ($IgG$, $IgA$, and $IgM$), are unique because they are not produced by the liver; instead, they are synthesized by plasma cells. Finally, Fibrinogen represents $7\%$ of the proteins and exists as a massive soluble molecule. During the coagulation process, it is cleaved by the enzyme thrombin and polymerizes to form an insoluble, structural fibrin network.

Erythrocyte Biology: Gas Transport Engineering

Erythrocytes, or red blood cells, represent $42\%\text{ to }47\%$ of the whole blood volume and are the most abundant cells in the human body. Their morphology is characterized by a biconcave disk shape, a design that maximizes the surface-to-volume ratio and provides high deformability. This flexibility allows them to transit through splenic capillaries as narrow as $3\,\mu m$. Biologically, mature erythrocytes are anucleated and lack organelles and mitochondria. Consequently, they do not consume the oxygen they transport, relying instead on anaerobic metabolism. They circulate for a lifespan of approximately $120\,\text{days}$ before reaching senescence, at which point they are recognized and phagocytosed by macrophages in the spleen.

Granulocytes: The Polynuclear First Line of Defense

Leukocytes represent approximately $1\%$ of the total blood volume and serve as the defenders of the immune system. The granulocyte category includes three cell types. Neutrophils are the most prevalent ($50\%\text{ to }60\%$) and have a very short lifespan ranging from hours to a few days. They die upon performing phagocytosis. A clinical alert is the presence of "band cells" (cayados) or immature neutrophils in circulation, which indicates that the body's mature reserves are exhausted during systemic bacterial infections. Eosinophils ($1\%\text{ to }3\%$) contain proteins highly toxic to parasites (specifically helminths) and release enzymes to degrade histamine, thereby regulating allergic reactions. Basophils ($0.3\%\text{ to }0.5\%$) contain potent inflammatory mediators, including histamine and heparin, and play a central role in hypersensitivity reactions.

Agranulocytes and Platelets: Adaptive Immunity and Hemostasis

Agranulocytes include Lymphocytes ($20\%\text{ to }30\%$), which are the key cells of adaptive immunity and include T cells, B cells, and Natural Killer ($NK$) cells. These cells constantly recirculate between the bloodstream and lymphoid organs. Monocytes ($3\%\text{ to }8\%$) are the largest blood cells. Upon migrating into tissues, they mature into specialized macrophages, such as Kupffer cells in the liver and Microglia in the Central Nervous System ($CNS$). They are involved in chronic phagocytosis and antigen presentation.

Platelets, or thrombocitos, are anucleated cytoplasmic fragments derived from megakaryocytes with a lifespan of $8\%\text{ to }9\,\text{days}$. They contain two types of granules: Alpha granules, which hold fibrinogen and von Willebrand Factor ($vWF$), and Dense granules, which store $ADP$ and serotonin.

Hematopoiesis Dynamics and Anatomical Sites

In the fetal stage, blood production begins in the yolk sac before transitioning to the liver and the spleen. In adults, hematopoiesis is medullary, restricted to the bone marrow of the axial skeleton, including the pelvis, sternum, ribs, and vertebrae. The marrow in long bones eventually matures into yellow marrow, composed of inactive adipocytes. Clinical alerts regarding extramedullary hematopoiesis occur during medullary failure or extreme demand, such as severe hemolytic anemias; in these cases, the liver and spleen reactivate production, leading to hepatosplenomegalia.

Cellular Lineages and Growth Factor Regulation

All blood cells originate from Pluripotential Hematopoietic Stem Cells ($HSC$), which possess the critical capacity for self-renewal and multipotential derivation. These cells divide into two branches: the Lymphoid line, which produces T lymphocytes, B lymphocytes, and $NK$ cells; and the Myeloid line, which produces erythrocytes, megakaryocytes, granulocytes, and monocytes. Hematopoiesis is regulated by cytokines known as hematopoietic growth factors, which induce proliferation, guide differentiation, and prevent apoptosis. Key factors include Erythropoietin ($EPO$), produced by the kidneys in response to hypoxia; Thrombopoietin ($TPO$), produced by the liver and kidneys to stimulate megakaryocytes; and Colony Stimulating Factors ($CSF$). Specific $CSF$ types include $GM-CSF$ (broad spectrum for granulocytes, monocytes, erythrocytes, and megakaryocytes), $G-CSF$ (specific for neutrophil proliferation), and $M-CSF$ (inducing macrophage colonies).

Stem Cell Alterations: From Aplasia to Proliferation

Pathological states of stem cells include destruction or failure, such as Aplastic Anemia, which can be caused by toxins, radiation, or autoimmunity. This leads to Pancitopenia, defined as the simultaneous reduction of erythrocytes, leukocytes, and platelets. Conversely, mutations can lead to excess production, known as Myeloproliferative Disorders, characterized by clonal overproduction. Examples include Polycythemia (unregulated erythrocyte mass) and Leukemias. Therapeutic solutions often involve stem cell transplants (bone marrow or umbilical cord blood), which can be autologous (from the recipient) or allogeneic (from a histocompatible donor).

Diagnostic Tests: Hemogram and Hematimetric Indices

The Hemogram is the primary diagnostic tool. Reticulocytes measure immature erythrocytes and provide a primary index for evaluating the bone marrow's response to anemia. Hematocrit ($Hct$) represents the percentage of erythrocyte volume and is generally three times the value of Hemoglobin ($Hb$). Normal values for men are $Hb: 13.5-17.5\,g/dL$, $Hct: 41-53\%$, and for women are $Hb: 12.0-15.5\,g/dL$, $Hct: 36-46\%$. Severe dehydration can artificially elevate the $Hct$ by reducing plasma volume.

Mean Corpuscular Volume ($VCM$) ranges from $85-100\,fL$ and classifies anemias by size: Microcytic (iron deficiency), Normocytic, or Macrocytic ($B_{12}$ or folate deficiency). Mean Corpuscular Hemoglobin Concentration ($CHCM$) determines cell color, classifying cells as Hypochromic (pale) or Normochromic, with a normal value of $32-36\,g/dL$.

Visual Inspection and Erythrocyte Sedimentation Rate (ESR)

A Peripheral Smear allows for morphological observation. Specific findings include Spherocytes (cells lacking central pallor), Schistocytes (fragments from mechanical hemolysis), and Blasts (immature cells indicating severe pathology). The Erythrocyte Sedimentation Rate ($ESR\text{ or }VES$) is an inespecific marker of inflammation. Under normal conditions, erythrocytes repel each other due to a negative surface charge ($Zeta potential$). In inflammatory states, the liver releases asymmetric fibrinogen that neutralizes this charge, causing erythrocytes to stack in "Rouleaux" (stacks of coins), which increase in weight and sediment faster.

Invasive Marrow Evaluation: Aspiration vs. Biopsy

Marrow evaluation is indicated for severe anomalies or unexplained cytopenias. Aspiration involves extracting liquid marrow for cytological study (fristis) to observe individual cell morphology and search for leukemic blasts. The normal myeloid-to-erythroid ratio is $3:1$ or $4:1$. A Bone Biopsy, often performed in children using a Jamshidi needle, extracts an intact bone cylinder for histological study. This evaluates tissue architecture, cellularity vs. fat ratio, and focal pathologies like fibrosis or metastasis.

Hemostasis Phases: Vasoespasmo and Platelet Plug

Hemostasis occurs in distinct phases. Phase 1 is the Vasospasm (lasting $<1\,\text{min}$), which is an immediate reflex response involving local vasoconstriction mediated by endothelin (from the vessel) and Thromboxane $A_2$ (from platelets). Phase 2 is Primary Hemostasis (seconds), resulting in the formation of a Platelet Plug. This involves Adhesion, where von Willebrand Factor ($vWF$) links exposed collagen to the platelet receptor glycoprotein $Ib$, followed by Activation and Aggregation where platelets change shape and release $ADP$ and $TxA_2$. Pharmacological intervention using $COX-1$ inhibitors (Aspirin) blocks this platelet activation step irreversibly to prevent heart attacks and strokes.

Secondary Hemostasis: The Coagulation Cascade

Phase 3 is Secondary Hemostasis, or the Coagulation Cascade. The Intrinsic Pathway is relatively slow (minutes) and is activated by contact with the subendothelial matrix. The Extrinsic Pathway is rapid (seconds) and is activated by tissue factor (thromboplastin) released by massive cell damage. Both converge at the Common Pathway by activating Factor X. This factor converts Prothrombin into Thrombin, the master enzyme. Thrombin then cleaves fibrinogen to form a stable fibrin network. Essential requirements for this system include Vitamin K (for hepatic synthesis of Factors $II, VII, IX, X$, and Proteins C and S) and Calcium (Factor $IV$, required throughout the cascade).

Resolution: Retraction and Fibrinolysis

Phase 4 is Retraction ($20\%\text{ to }60\,\text{min}$), where platelet contractile proteins actin and myosin contract, squeezing out serum and compacting the clot to close the vessel edges. Phase 5 is Fibrinolysis, the final phase. Healthy endothelium releases $tPA$, which converts plasminogen into plasmin. Plasmin then digests the fibrin threads, restoring blood flow and producing D-dimer as a degradation product. Clinical correlations differentiate primary defects (platelets), which cause immediate mucocutaneous bleeding like petechiae, from secondary defects (coagulation factors), which causes delayed deep bleeding such as hemarthrosis and large bruises.

Hypercoagulability and Virchow's Triad

Hypercoagulability is governed by Virchow's Triad: endothelial lesion, stasis (blood stagnantion), and systemic hypercoagulability. Risk factors include smoking, diabetes, hyperlipidemia, pregnancy, oral contraceptives ($ACO$), immobility, heart failure, and cancer. Thrombocytosis (platelet count $>1,000,000/\mu L$) can be Reactive (secondary to inflammation or iron deficiency) or Essential (primary clonal disorder), where platelets are dysfunctional, paradoxically causing both thrombosis and hemorrhage.

Genetic and Acquired Hypercoagulability Disorders

Hereditary alterations include Factor V Leiden, the most common mutation where the factor resists degradation by Protein C, and Prothrombin gene mutations that elevate plasma levels. Acquired alterations are often hormonal, as estrogens increase hepatic synthesis of factors. Antiphospholipid Syndrome is an autoimmune disorder characterized by recurrent thrombosis, spontaneous abortions, and mild thrombocytopenia, requiring constant anticoagulation with heparin and warfarin.

Bleeding Alterations: Platelet and Factor Failures

Bleeding disorders are categorized by their origin. Platelet disorders include Thrombocitopenia (count $<150,000/\mu L$, severe at $<20,000/\mu L$) caused by autoimmune destruction ($PTI$), consumption ($PTT$), or marrow failure. Heparin-induced thrombocytopenia ($TIH$) affects $50\%$ of patients within $2-5\,\text{days}$. Thrombocitopathies involve normal counts but altered function due to drugs or uremia. Coagulation factor disorders include von Willebrand Disease ($vWD$), Hemophilia A (Factor $VIII$ deficit), and Hemophilia B (Factor $IX$ deficit). Vascular disorders causing petechiae include Scurvy (Vitamin C deficit), Cushing's, and Vasculitis.

Disseminated Intravascular Coagulation (CID)

$CID$ is a fatal paradox and never a primary condition. It is a simultaneous state of massive hypercoagulability and profuse hemorrhage. It complicates sepsis, trauma, or neoplasias. The sequence involves massive activation of the cascade, formation of microthrombi causing multi-organ ischemia, and the eventual total consumption of platelets and factors, leading to massive hemorrhage from all orifices. Critical support involves treating the underlying cause and reponing plasma, platelets, and cryoprecipitates. The use of heparin here is highly controversial.

Hemoglobin Synthesis and Erythrocyte Metabolism

Adult Hemoglobin ($HbA$) comprises two alpha ($\alpha$) and two beta ($\beta$) chains, each containing a porphyrin ring and a ferrous iron ($Fe^{2+}$) atom responsible for binding oxygen. Fetal Hemoglobin ($HbF$) contains gamma ($\gamma$) chains instead of beta chains and has a higher affinity for oxygen. Erythrocytes produce $ATP$ purely through anaerobic glycolysis due to the lack of mitochondria. They utilize the hexose monophosphate pathway to produce $NADPH$, which maintains reduced glutathione to neutralize free radicals. Ensymatic failures like $G6PD$ deficiency lead to hemoglobin precipitation (Heinz bodies) and severe hemolysis.

Erythrocyte Life Cycle and Recycling

Hypoxia triggers the kidneys to secrete $90\%$ of the body's Erythropoietin ($EPO$), stimulating marrow proerythroblasts to mature into reticulocytes and enter circulation. After $120\,\text{days}$, senescent erythrocytes are trapped in splenic sinusoids and destroyed by macrophages. Approximately $80\%$ of the iron is recycled via transferrin and stored as ferritin. The porphyrin ring is converted into biliverdine, then unconjugated bilirubin, which the liver conjugates for bile. If destruction exceed hepatic capacity, unconjugated indirect bilirubin accumulates, causing jaundice.

Immunohematology and Transfusion Reactions

The ABO system is based on antigens; individuals develop natural $IgM$ antibodies against antigens they lack (e.g., Group O has Anti-A and Anti-B). AB is the universal recipient, and O is the universal donor. The Rh system (D antigen) involves $IgG$ antibodies that are not natural but result from sensitization (pregnancy or previous transfusions). Acute transfusion reactions include acute hemolytic reaction (ABO incompatibility activating complement), $TRALI$ (lung injury from donor antibodies attacking recipient neutrophils), and $TACO$ (circulatory overload). Late reactions include delayed hemolytic reactions mediated by $IgG$ against minor antigens like Kidd or Kell.

Pathophysiological Classification of Anemias

Anemia is a sign of decreased erythrocyte mass resulting in tissue hypoxia and tachycardia. It is classified by mechanism: blood loss (acute or chronic), peripheral destruction (hemolysis), or deficient production. Morphologically, Microcytic-Hypochromic anemias include iron deficiency and thalassemias. Normocytic-Normochromic anemias include acute hemorrhage and aplastic anemia. Macrocytic-Normochromic anemias include megaloblastic anemia from $B_{12}$ or folate deficiency. A key differentiator is that only $B_{12}$ deficiency produces neurological demyelination.

Hereditary Hemolytic Anemias

Hereditary Spherocytosis involves a defect in spectrin, resulting in rigid spherical cells that undergo splenic hemolysis. Sickle Cell Anemia (Drepanocitosis) involves a glutamic acid to valine mutation producing $HbS$; under hypoxia, the cell takes a sickle shape, causing vaso-occlusions and pain. Thalassemias are genetic defects in alpha or beta chain synthesis leading to deep microcytosis and intramedullary destruction.

Anemia of Chronic Disease and Aging

Anemia of chronic disease is characterized by the "sequestering" of iron. Systemic inflammation causes the release of hepcidin, which blocks ferroportina channels, trapping iron inside macrophages even though ferritin levels are normal or high. Regarding aging, anemia is NEVER a normal consequence of growing old. While hematopoietic reserves decrease, falling hemoglobin always requires diagnostic investigation to rule out occult gastrointestinal blood loss or chronic disease. In neonates, uncontrolled indirect bilirubin can cross the blood-brain barrier, causing irreversible damage known as Kernicterus.

Leukocyte Pathologies and Neoplasms

Neutropenia is defined as an Absolute Neutrophil Count ($ANC$) $< 1,500/\mu L$, while Agranulocytosis corresponds to $ANC < 200/\mu L$, leading to an inability to form pus and risk of septic shock. In Infectious Mononucleosis ($EBV$), massive lymphoid infiltration creates a risk of splenic rupture. Lymphomas are solid neoplasms of lymphoid tissues, classified into Hodgkin and Non-Hodgkin. Leukemias are clonal replacements of marrow: Acute Lymphoblastic Leukemia ($LLA$) is most common in children, while Acute Myeloid Leukemia ($LMA$) is predominant in adults. Chronic Lymphocytic Leukemia ($LLC$) is seen in the elderly. Chronic Myeloid Leukemia ($LMC$) is identified by the Philadelphia Chromosome and treated with tyrosine kinase inhibitors. Finally, Multiple Myeloma represents a clonal proliferation of plasma cells following the CRAB model (calcium elevation, renal failure, anemia, bone lesions).